Long intergenic non-protein coding RNA 1517 (LINC01517)

Long intergenic non-protein coding RNA 1517 (LINC01517) is a long intergenic non-coding RNA (lincRNA), meaning it is a non-coding RNA transcript longer than 200 nucleotides that does not overlap with any known protein-coding genes[1][3]. LINC01517, like other lincRNAs, is autonomously transcribed and is part of a diverse and expanding class of RNAs distinguished by the lack of protein-coding potential. lincRNAs are increasingly recognized for their roles in regulating chromatin architecture, influencing the transcription of nearby or distant genes, stabilizing RNA, and participating in diverse regulatory networks within the cell. These RNAs may act through a variety of mechanisms, including direct interaction with chromatin regulators, acting as molecular scaffolds, or modulating protein localization and function[1][5]. The specific biological or pathological role of LINC01517 remains uncharacterized in the current scientific literature and databases, and it is not considered a conventional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[3]. Current knowledge places LINC01517 into the broader group of long non-coding RNAs (lncRNAs), with possible regulatory roles but no direct involvement as a drug target, biomarker, or mechanistic participant in clinical therapeutics at this time[1][3][5].

Other names

LINC01517bA492M23.1C10orf126

Not applicable (no known drugs or therapeutic targeting)